Cardiac Embolism

Published on 12/04/2015 by admin

Filed under Neurology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2178 times

Chapter 4 Cardiac Embolism

Cardiac embolism represents one of the most common mechanisms of ischemic stroke. It is most common in the elderly as a consequence of the high incidence of atrial fibrillation, but it is also one of the most frequent causes of stroke in the young. Yet several factors often make the diagnosis of cardiac embolism complicated: (1) cardiac embolism can produce infarctions in any vascular distribution; (2) some of the potential sources of cardiac embolism are prevalent in the general population; (3) cardioembolic sources often coexist with atherosclerotic vascular lesions in the cerebral vasculature. Furthermore, even when the diagnosis of a cardioembolic stroke is typically followed by the initiation of anticoagulation for secondary prevention, this intervention has only been scientifically validated for atrial fibrillation and mechanical valve prosthesis. With these caveats in mind, Table 4-1 lists the potential causes of cardiac embolism divided according to the strength of the evidence supporting the pathophysiological association.

TABLE 4-1 Cardiac sources of embolism.

Definite
Atrial fibrillation (chronic and paroxysmal)*
Mechanical valve prosthesis
Rheumatic valve disease
Infective endocarditis
Nonbacterial thrombotic endocarditis
Dilated cardiomyopathy with severely reduced left ventricular ejection fraction
Acute transmural myocardial infarction (especially of the anterior wall)
Mural thrombi
Apical aneurysm
Left atrial thrombus
Atrial myxoma
Probable
Patent foramen ovale with atrial septal aneurysm
Biological prosthetic valves (early after surgery)
Possible
Patent foramen ovale
Spontaneous echo contrast
Left atrial enlargement
Degenerative mitral or aortic valve disease
Valve strands
Mitral annular calcification
Valvular fibroelastoma
Nondilatated cardiomyopathies
Sick sinus syndrome

* Includes atrial flutter.

Brain infarctions caused by cardiac embolism tend to share similar radiological characteristics regardless of the type of cardiac disease responsible for the embolism. These general characteristics are listed in Table 4-2 and illustrated in Figure 4-1. The pattern of acute multiple bilateral infarctions on diffusion-weighted imaging (DWI), especially when involving the anterior and posterior circulation territories, is strongly associated with cardiac embolism.1,2 Infarctions with embolic appearance and acute multiple brain infarctions on DWI24 should raise suspicion of a cardiac source but may also be produced by artery-to-artery embolism. In fact, it is essentially impossible solely on the basis of brain imaging to distinguish cardioembolic infarctions from infarctions due to aortic embolism. It is important to keep in mind that cardioembolic strokes can have atypical presentations, such as relatively small subcortical infarctions.5 Thus the presence of radiological features highly suggestive of cardiac embolism should prompt comprehensive cardiac assessment, but their absence does not exclude the possibility of a cardioembolic mechanism.

TABLE 4-2 Radiological characteristics of cardioembolic strokes.

Wedge-shaped infarctions based in the cortex
Concurrent acute bilateral infarctions
Concurrent acute infarctions in the anterior and posterior circulations
Multiple cortical infarctions in various vascular distributions (even if infarctions are of different ages)
Greater tendency to hemorrhagic transformation

The advent of echocardiography, particularly transesophageal echocardiography (TEE), has provided a wealth of information on various cardiac abnormalities that may increase the risk of ischemic stroke. Transthoracic echocardiography (TTE) provides better visualization of the left ventricle and mitral valve, but it typically adds little to TEE in the evaluation of stroke patients. TEE offers better visualization of the left atrium, left atrial appendage, interatrial septum, aortic valve, and aortic arch. The superiority of TEE for the study of the cardiac structures more commonly associated with embolism makes it the preferred choice for the evaluation of cardiac embolism in combination with electrocardiography (to detect myocardial ischemia and arrhythmias) and Holter monitoring (to recognized paroxysmal arrhythmias not apparent on the electrocardiogram [ECG]).6 TTE is justified when myocardial ischemia, areas of ventricular hypokinesis/akinesis, or dilatated cardiomyopathy are suspected by the history or the initial ECG. Although we strongly advocate the use of TEE for the study of cardiac sources of embolism after a transient ischemic attack (TIA) or stroke, in this chapter we present several examples of diagnostic TTE, because it was the institutional practice at Jackson Memorial Hospital’University of Miami to perform a transthoracic study first.

This chapter summarizes information on the most commonly encountered sources of cardiac embolism. It presents various illustrations of the radiological pattern of the brain infarctions and echocardiographic appearance of the cardiac disorders. It concludes with a reference to aortic, embolism, which that is included here because its diagnosis hinges on the use of TEE and the neuroimaging features of strokes caused by aortic embolism are essentially indistinguishable from those due to cardiac embolism.

ATRIAL FIBRILLATION

Case Vignette

A 72-year-old man with history of hypertension, dyslipidemia, and coronary artery disease presented with sudden left-sided weakness. Examination revealed an irregularly irregular pulse, left visual field deficit, left hemiparesis, and left hemihypoesthesia with neglect. ECG confirmed the suspicion of atrial fibrillation, and brain imaging showed a right middle cerebral artery infarction (Figure 4-2). TEE was remarkable for left atrial enlargement but did not show any atrial thrombus or dense spontaneous echo contrast. The patient was initially treated with aspirin because of concerns about possible hemorrhagic transformation of the cerebral infarction. Beta-blockers were successful in maintaining the ventricular rate controlled. Warfarin was started 3 days after the stroke without complications. The patient evolved favorably and remained free of stroke recurrence 3 years later.

Anticoagulation is clearly indicated for primary and secondary stroke prevention in patients with atrial fibrillation.15 Aspirin should only be used in patients with low risk of thromboembolic complications (i.e., young age, no cardiovascular risk factors, absence of echocardiographic markers of increased embolic risk).15 When anticoagulation is contraindicated by concurrent conditions, aspirin is prescribed and radiofrequency ablation procedures to restore sinus rhythm permanently are an option. Percutaneous occlusion of the left atrial appendage is being investigated as another alternative for these cases.16

DILATED CARDIOMYOPATHY

Anticoagulation is generally accepted as the optimal strategy for secondary prevention after a stroke attributed to dilated cardiomyopathy.17 For primary stroke prevention, anticoagulation is only indicated in patients with documented atrial fibrillation or left ventricular thrombus17 but might be useful in patients without these complicating conditions as well.18

MYOCARDIAL INFARCTION

Anticoagulation for at least 3 to 6 months is recommended for patients with stroke due to acute myocardial infarction with documented left ventricular mural thrombus.20 In patients with transmural myocardial infarction but without documented mural thrombus, short-term anticoagulation may be justified if the stroke was attributed to concurrent myocardial ischemia.

INFECTIVE ENDOCARDITIS

Stroke complicates 10% to 40% of cases of infective endocarditis.2123 Most strokes occur at presentation or within 48 hours of diagnosis.23,24 After adequate antibiotic therapy is instituted, the embolic risk falls substantially.24,25 The risk of stroke may be higher in patients with mitral valve endocarditis than in those with aortic vegetations (Figure 4-11).23
The risk of intracranial hemorrhage is also considerably increased in patients with infective endocarditis (see Chapter 11). It may be caused by hemorrhagic conversion of an ischemic infarction or by rupture of a mycotic aneurysm. Small hemorrhagic components are commonly seen within ischemic infarctions on hemosiderin-sensitive sequences of magnetic resonance imaging (MRI). Mycotic aneurysms are typically small and located in the distal circulation; conventional angiography is necessary to exclude their presence because noninvasive angiographic techniques may not be sufficiently sensitive to detect them. When they rupture, they most often produce subarachnoid hemorrhage predominantly around the hemispheric convexity.

PROSTHETIC VALVES

NONBACTERIAL THROMBOTIC ENDOCARDITIS

Case Vignette

A 42-year-old woman without previous medical problems presented with acute left inferior quadrantanopsia, left hemiparesis, and diffuse petechiae in all limbs. Brain computed tomography (CT) showed high fronto-parietal hypodensities involving the cortex (Figure 4-13, A). Blood studies revealed thrombocytopenia (40,000 per mm3), leukocytosis (30,000 per mm3) and elevated lactate dehydrogenase (5060 U/L). An electrocardiogram disclosed inverted T waves in the inferior leads. Heparin and aspirin were started. Hours after admission, she developed excruciating left flank pain and became confused. Examination showed a pulseless and cold right foot. After four blood cultures were obtained, the patient was empirically started on antibiotics and high-dose dexamethasone. She improved over the following day, with less pain, improved foot temperature, and increasing platelet count. However, she remained confused and exhibited more ecchymotic lesions and subungual splinter hemorrhages (Figure 4-13, B and C). Chest CT revealed large mediastinal lymphadenopathy, and CT of abdomen showed multiple splenic and renal infarcts. Testing for cryoglobulins, antinuclear antibodies, antiphospholipid antibodies, complement levels, as well as serial blood cultures were negative. Transthoracic echocardiogram (TTE) (Figure 4-13, D) showed a large vegetation attached to the aortic valve, with moderate aortic regurgitation and moderate posterior and apical hypokinesis. The patient underwent aortic valve replacement, and pathological examination revealed marantic vegetations with myxoid degeneration of the removed valve. Stains and cultures of the vegetations were negative. After surgery, she developed bilateral leg ischemia, renal failure, and congestive heart failure due to global left ventricular hypokinesis documented by a new TTE that revealed acceptable function of the prosthetic aortic valve. She expired 7 days after the surgery. Necropsy findings included metastatic adenocarcinoma of unknown primary involving paratracheal nodes and pleura, bilateral kidney and splenic infarctions, congestive hepatomegaly, serosanguineous pleural effusions and ascites, large organizing right cerebral infarcts, and microscopic cerebellar infarcts. The prosthetic valve was covered by multiple vegetations that resulted in partial luminal occlusion.

ATRIAL MYXOMA

Ischemic stroke is the most common neurological presentation of atrial myxomas (Figure 4-15).34 The proposed mechanism for the infarctions, which are often multiple, bilateral, and recurrent, is embolism of tumor fragments facilitated by the friable consistency of the mass.

PATENT FORAMEN OVALE

Case Vignette

A 44-year-old woman presented with sudden left-sided weakness and paresthesias and problems with speech articulation. Her symptoms had started after she had tried to lift a heavy box from the floor. Her only risk factors for atherosclerosis were obesity and smoking. Her medical history was otherwise significant for a previous episode of deep venous thrombosis in one leg 3 years before, which was considered spontaneous and had been treated with nearly 6 months of anticoagulation. Brain imaging revealed small cortical infarctions in the posterior right frontal lobe (Figure 4-17, A). Carotid ultrasound was unrevealing, and ECG showed sinus rhythm. Transthoratic echocardiogram with bubble study disclosed a patent foramen ovale (PFO) (Figure 4-17, B). The right-to-left shunt at rest and exacerbated with Valsalva was subsequently confirmed by transcranial Doppler (Figure 4-17, D–F). Venous Doppler of the lower extremities showed an acute deep venous thrombosis in the right leg (Figure 4-17, C). Hypercoagulability workup was positive for factorLeiden mutation (heterozygous). The patient was treated with oral anticoagulation and had no stroke recurrences at the last follow-up 32 months later.

PFO associated with atrial septal aneurysm (ASA) is associated with increased incidence of recurrent stroke in young patients (< 55 years old) with cryptogenic cerebral infarctions.3638 Even in the absence of concomitant ASA, PFO can be responsible for embolic brain infarctions, especially in young patients with deep venous thrombosis or thrombophilia (Figure 4-17).
It is important to remember that PFO is a common finding in healthy individuals (prevalence of 25% in a population study).40 In fact, PFO is not an independent risk factor for cerebrovascular events in the general population,41,42 and it has not been consistently found to be associated with increased risk of recurrent stroke among unselected patients with cryptogenic strokes.43
The diagnosis of PFO and ASA hinges on the use of echocardiography, particularly TEE (see Figures 4-17, 4-18, 4-19). TEE allows visualization of the PFO, recognition and grading of right-to-left shunt (defined by the appearance of microbubbles in the left atrium within 3 to 5 cardiac cycles following injection of 5 to 10 ml of agitated saline solution into a peripheral vein), and detection of ASA (bulging of the region of the fossa ovalis extending 15 mm or more beyond the plane of the atrial septum). Contrast echocardiography may enhance the sensitivity of the technique.
Transcranial Doppler (TCD) is also an effective method to diagnose the presence of a right-to-left shunt (Figure 4-17). The shunt is demonstrated by detecting microembolic signals’corresponding to microbubbles’in an intracranial vessel (typically one of the middle cerebral arteries) after infusion of agitated saline in a peripheral vein of the arm. The sensitivity of TCD is comparable that of TEE.45 In fact, we have seen patients with PFO diagnosed by TCD after being missed by TEE because the patients had been too sedated during TEE to perform adequate Valsalva. However, TCD can only prove the existence of a right-to-left shunt rather than a PFO. The degree of shunting can be quantified by TCD,46 but this method does not allow assessment of the characteristics of the PFO itself or presence of an ASA. Hence, TCD and TEE should be considered complementary techniques.47 Use of contrast TCD, and performing the test twice using two provocation maneuvers (e.g., coughing and standard Valsalva) may increase the diagnostic sensitivity of the method.48
Larger PFOs may be associated with higher risk of cryptogenic strokes than smaller ones.43,49 Presence of right-to left shunt at rest (as opposed to only with Valsalva maneuver) may also increase the risk for recurrent brain embolism.50 In addition, presence of concomitant ASA correlates with the occurrence of multiple acute DWI lesions, even after controlling for PFO size and degree of right-to-left shunt.51
The optimal treatment of patients with ischemic stroke ascribed to PFO and ASA remains to be established.36 Although there is insufficient evidence to support the use of anticoagulation, most experts favor this approach over antiplatelet therapy. Ongoing trials are testing the value of endovascular closure of PFO.

PROXIMAL AORTIC ATHEROSCLEROTIC PLAQUE

Case Vignette

A 76-year-old man with history of hypertension, hyperlipidemia, smoking, coronary artery disease, peripheral vascular disease with claudication, and previous right carotid endarterectomy for severe, asymptomatic stenosis presented with acute right sided weakness. Examination confirmed the presence of right hemiparesis but also disclosed a left visual field deficit. CT scan of the brain showed cortical infarctions in the left frontal and right occipital lobes (Figure 4-20, A and B). Carotid duplex showed moderate stenosis on the left internal carotid origin and no significant restenosis on the right side. Electrocardiography and cardiac telemetry proved that the patient was in sinus rhythm. TEE showed extensive aortic arch atherosclerosis including a thick focal plaque with an area of small ulceration on its surface. Although there was no mobile component in the aortic plaque, the patient was treated with oral anticoagulation for 3 months along with low-dose aspirin, high-dose statin, and adjustment in the doses of his antihypertensive agents. The patient recovered favorably with help from rehabilitation services, and repeat TEE 3 months later showed reduction in the size of the larger aortic arch plaque. Warfarin was stopped, and he was continued on aspirin without stroke recurrence.

Complex atherosclerotic plaques (defined by thickness > 4 mm, presence of ulceration, and/or mobile component) in the proximal aorta (ascending or arch) are associated with an increased risk of embolic stroke (Figure 4-20). This association has been consistently found in several case-control studies.52,53 Among stroke patients referred for evaluation with TEE, the prevalence of complex proximal aortic plaques is 14% to 21%, and the 1-year incidence of stroke is 10% to 12%.54,55
In a population-based study the rate of complex proximal aortic plaques was much lower (2.4%) than in selected populations of stroke patients.56 In this community-based study free of referral bias, there was no association between the presence of complex proximal aortic plaques and the occurrence of embolic strokes over a 5-year follow-up. In the same population, the presence of complex atherosclerotic debris was not associated with the occurrence of cryptogenic strokes.57 However, the low number of patients with complex proximal aortic plaques may have undermined the power of the study to test the likelihood of these associations.
Careful study of the aortic arch using TEE or intraoperative epiaortic ultrasound is helpful in reducing the risk of perioperative aortoembolic complications.63,64 The option of off-pump bypass surgery in patients with high aortic plaque burden should be considered.65 Prophylactic aortic arch endarterectomy should not be performed because it has been shown to increase the risk of serious embolization.66

References

1 Wessels T, Wessels C, Ellsiepen A, Reuter I, Trittmacher S, Stolz E, et al. Contribution of diffusion-weighted imaging in determination of stroke etiology. AJNR Am J Neuroradiol. 2006;27:35-39.

2 Kang DW, Chalela JA, Ezzeddine MA, Warach S. Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes. Arch Neurol. 2003;60:1730-1734.

3 Roh JK, Kang DW, Lee SH, Yoon BW, Chang KH. Significance of acute multiple brain infarction on diffusion-weighted imaging. Stroke. 2000;31:688-694.

4 Baird AE, Lovblad KO, Schlaug G, Edelman RR, Warach S. Multiple acute stroke syndrome: marker of embolic disease? Neurology. 2000;54:674-678.

5 Seifert T, Enzinger C, Storch MK, Pichler G, Niederkorn K, Fazekas F. Acute small subcortical infarctions on diffusion weighted MRI: clinical presentation and aetiology. J Neurol Neurosurg Psychiatry. 2005;76:1520-1524.

6 Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke. 2006;37:859-864.

7 Douen AG, Pageau N, Medic S. Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke. Stroke. 2008;39:480-482.

8 Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004;35:1647-1651.

9 Liao J, Khalid Z, Scallan C, Morillo C, O’Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke. 2007;38:2935-2940.

10 Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation. 1995;92:835-841.

11 Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med. 1992;116:6-12.

12 Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol. 1998;31:1622-1626.

13 The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med. 1998;128:639-647.

14 Strandberg M, Raatikainen MJ, Niemela M, Luotolahti M, Hartiala J, Airaksinen KE. Clinical practicality and predictive value of transesophageal echocardiography in early cardioversion of atrial fibrillation. Europace. 2006;8:408-412.

15 Hart RG, Sherman DG, Easton JD, Cairns JA. Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology. 1998;51:674-681.

16 Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol. 2005;46:9-14.

17 Koniaris LS, Goldhaber SZ. Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol. 1998;31:745-748.

18 Pullicino PM, Halperin JL, Thompson JL. Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology. 2000;54:288-294.

19 Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251-257.

20 Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113:e409-e449.

21 Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Hofer D, Poewe W, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-2099.

22 Delahaye JP, Poncet P, Malquarti V, Beaune J, Gare JP, Mann JM. Cerebrovascular accidents in infective endocarditis: role of anticoagulation. Eur Heart J. 1990;11:1074-1078.

23 Anderson DJ, Goldstein LB, Wilkinson WE, Corey GR, Cabell CH, Sanders LL, et al. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology. 2003;61:1341-1346.

24 Hart RG, Foster JW, Luther MF, Kanter MC. Stroke in infective endocarditis. Stroke. 1990;21:695-700.

25 Salgado AV, Furlan AJ, Keys TF, Nichols TR, Beck GJ. Neurologic complications of endocarditis: a 12-year experience. Neurology. 1989;39:173-178.

26 Singhal AB, Topcuoglu MA, Buonanno FS. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke. 2002;33:1267-1273.

27 Paschalis C, Pugsley W, John R, Harrison MJ. Rate of cerebral embolic events in relation to antibiotic and anticoagulant therapy in patients with bacterial endocarditis. Eur Neurol. 1990;30:87-89.

28 Hart RG, Kagan-Hallet K, Joerns SE. Mechanisms of intracranial hemorrhage in infective endocarditis. Stroke. 1987;18:1048-1056.

29 Wijdicks EF, Schievink WI, Brown RD, Mullany CJ. The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery. 1998;42:769-773.

30 Biller J, Challa VR, Toole JF, Howard VJ. Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol. 1982;39:95-98.

31 Rogers LR, Cho ES, Kempin S, Posner JB. Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation. Am J Med. 1987;83:746-756.

32 Rabinstein AA, Giovanelli C, Romano JG, Koch S, Forteza AM, Ricci M. Surgical treatment of nonbacterial thrombotic endocarditis presenting with stroke. J Neurol. 2005;252:352-355.

33 Nair CK, Thomson W, Ryschon K, Cook C, Hee TT, Sketch MH. Long-term follow-up of patients with echocardiographically detected mitral anular calcium and comparison with age- and sex-matched control subjects. Am J Cardiol. 1989;63:465-470.

34 Ekinci EI, Donnan GA. Neurological manifestations of cardiac myxoma: a review of the literature and report of cases. Intern Med J. 2004;34:243-249.

35 Sabolek M, Bachus-Banaschak K, Bachus R, Arnold G, Storch A. Multiple cerebral aneurysms as delayed complication of left cardiac myxoma: a case report and review. Acta Neurol Scand. 2005;111:345-350.

36 Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;62:1042-1050.

37 Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740-1746.

38 Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55:1172-1179.

39 Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357:2262-2268.

40 Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O’Fallon WM, Pascoe RD, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc. 1999;74:862-869.

41 Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006;47:440-445.

42 Petty GW, Khandheria BK, Meissner I, Whisnant JP, Rocca WA, Christianson TJ, et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81:602-608.

43 Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625-2631.

44 Jauss M, Wessels T, Trittmacher S, Allendorfer J, Kaps M. Embolic lesion pattern in stroke patients with patent foramen ovale compared with patients lacking an embolic source. Stroke. 2006;37:2159-2161.

45 Belvis R, Leta RG, Marti-Fabregas J, Cocho D, Carreras F, Pons-Llado G, et al. Almost perfect concordance between simultaneous transcranial Doppler and transesophageal echocardiography in the quantification of right-to-left shunts. J Neuroimaging. 2006;16:133-138.

46 Ziai WC, Oh S, Razumovsky AY, Wityk RJ. Quantitation of contrast TCD in patients with and without atrial septal aneurysm. J Neuroimaging. 2005;15:250-253.

47 Droste DW, Schmidt-Rimpler C, Wichter T, Dittrich R, Ritter M, Stypmann J, et al. Right-to-left-shunts detected by transesophageal echocardiography and transcranial Doppler sonography. Cerebrovasc Dis. 2004;17:191-196.

48 Droste DW, Kriete JU, Stypmann J, Castrucci M, Wichter T, Tietje R, et al. Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts: comparison of different procedures and different contrast agents. Stroke. 1999;30:1827-1832.

49 Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke. 1998;29:944-948.

50 De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31:2407-2413.

51 Bonati LH, Kessel-Schaefer A, Linka AZ, Buser P, Wetzel SG, Radue EW, et al. Diffusion-weighted imaging in stroke attributable to patent foramen ovale: significance of concomitant atrial septum aneurysm. Stroke. 2006;37:2030-2034.

52 Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994;331:1474-1479.

53 Jones EF, Kalman JM, Calafiore P, Tonkin AM, Donnan GA. Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke. 1995;26:218-224.

54 Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I. High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol. 1994;23:1085-1090.

55 The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. 1996;334:1216-1221.

56 Meissner I, Khandheria BK, Sheps SG, Schwartz GL, Wiebers DO, Whisnant JP, et al. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study. J Am Coll Cardiol. 2004;44:1018-1024.

57 Petty GW, Khandheria BK, Meissner I, Whisnant JP, Rocca WA, Sicks JD, et al. Population-based study of the relationship between atherosclerotic aortic debris and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81:609-614.

58 Kronzon I, Tunick PA. Aortic atherosclerotic disease and stroke. Circulation. 2006;114:63-75.

59 Petty GW, Khandheria BK, Meissner I, Whisnant JP, Rocca WA, Sicks JD, et al. Population-based study of the relationship between atherosclerotic aortic debris and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81:609-614.

60 Tunick PA, Nayar AC, Goodkin GM, Mirchandani S, Francescone S, Rosenzweig BP, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol. 2002;90:1320-1325.

61 Lima JA, Desai MY, Steen H, Warren WP, Gautam S, Lai S. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation. 2004;110:2336-2341. 19

62 Ferrari E, Vidal R, Chevallier T, Baudouy M. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol. 1999;33:1317-1322.

63 Davila-Roman VG, Phillips KJ, Daily BB, Davila RM, Kouchoukos NT, Barzilai B. Intraoperative transesophageal echocardiography and epiaortic ultrasound for assessment of atherosclerosis of the thoracic aorta. J Am Coll Cardiol. 1996;28:942-947.

64 Gold JP, Torres KE, Maldarelli W, Zhuravlev I, Condit D, Wasnick J. Improving outcomes in coronary surgery: the impact of echo-directed aortic cannulation and perioperative hemodynamic management in 500 patients. Ann Thorac Surg. 2004;78:1579-1585.

65 Ascione R, Ghosh A, Reeves BC, Arnold J, Potts M, Shah A, et al. Retinal and cerebral microembolization during coronary artery bypass surgery: a randomized, controlled trial. Circulation. 2005;112:3833-3838.

66 Stern A, Tunick PA, Culliford AT, Lachmann J, Baumann FG, Kanchuger MS, et al. Protruding aortic arch atheromas: risk of stroke during heart surgery with and without aortic arch endarterectomy. Am Heart J. 1999;138(4 Pt 1):746-752.